U.S. flag

An official website of the United States government

NM_000157.4(GBA1):c.625C>T (p.Arg209Cys) AND not provided

Germline classification:
Pathogenic/Likely pathogenic (3 submissions)
Last evaluated:
May 17, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000179793.14

Allele description [Variation Report for NM_000157.4(GBA1):c.625C>T (p.Arg209Cys)]

NM_000157.4(GBA1):c.625C>T (p.Arg209Cys)

Genes:
LOC106627981:GBA recombination region [Gene]
GBA1:glucosylceramidase beta 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1q22
Genomic location:
Preferred name:
NM_000157.4(GBA1):c.625C>T (p.Arg209Cys)
HGVS:
  • NC_000001.11:g.155238270G>A
  • NG_009783.1:g.11428C>T
  • NG_042867.1:g.4732G>A
  • NM_000157.4:c.625C>TMANE SELECT
  • NM_001005741.2(GBA):c.625C>T
  • NM_001005741.3:c.625C>T
  • NM_001005742.3:c.625C>T
  • NM_001171811.2:c.364C>T
  • NM_001171812.2:c.478C>T
  • NP_000148.2:p.Arg209Cys
  • NP_001005741.1:p.Arg209Cys
  • NP_001005742.1:p.Arg209Cys
  • NP_001165282.1:p.Arg122Cys
  • NP_001165283.1:p.Arg160Cys
  • NC_000001.10:g.155208061G>A
  • NM_001005741.2(GBA):c.625C>T
  • NM_001005741.2:c.625C>T
  • P04062:p.Arg209Cys
Protein change:
R122C
Links:
UniProtKB: P04062#VAR_032404; dbSNP: rs398123532
NCBI 1000 Genomes Browser:
rs398123532
Molecular consequence:
  • NM_000157.4:c.625C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001005741.3:c.625C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001005742.3:c.625C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001171811.2:c.364C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001171812.2:c.478C>T - missense variant - [Sequence Ontology: SO:0001583]
Observations:
4

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000232100Eurofins Ntd Llc (ga)
criteria provided, single submitter

(EGL Classification Definitions)
Pathogenic
(Jul 18, 2012)
germlineclinical testing

Citation Link,

SCV002503550AiLife Diagnostics, AiLife Diagnostics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Dec 23, 2020)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

SCV004228231Mayo Clinic Laboratories, Mayo Clinic
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(May 17, 2023)
germlineclinical testing

PubMed (9)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes1not providednot providednot providednot providedclinical testing
not providedgermlineunknown3not providednot providednot providednot providedclinical testing

Citations

PubMed

Two novel polymorphic sequences in the glucocerebrosidase gene region enhance mutational screening and founder effect studies of patients with Gaucher disease.

Lau EK, Tayebi N, Ingraham LJ, Winfield SL, Koprivica V, Stone DL, Zimran A, Ginns EI, Sidransky E.

Hum Genet. 1999 Apr;104(4):293-300.

PubMed [citation]
PMID:
10369158

Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease.

Koprivica V, Stone DL, Park JK, Callahan M, Frisch A, Cohen IJ, Tayebi N, Sidransky E.

Am J Hum Genet. 2000 Jun;66(6):1777-86. Epub 2000 May 4.

PubMed [citation]
PMID:
10796875
PMCID:
PMC1378059
See all PubMed Citations (9)

Details of each submission

From Eurofins Ntd Llc (ga), SCV000232100.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided2not providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided2not providednot providednot provided

From AiLife Diagnostics, AiLife Diagnostics, SCV002503550.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (3)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not providednot providednot provided

From Mayo Clinic Laboratories, Mayo Clinic, SCV004228231.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (9)

Description

PP3, PP4, PM2, PM3_strong, PS4_moderate

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided1not providednot providednot provided

Last Updated: Oct 8, 2024